Accessibility Menu
 
Onconetix logo

Onconetix

(NASDAQ) ONCO

Current Price$0.62
Market Cap$2.22M
Since IPO (2022)-100%
5 YearN/A
1 Year-94%
1 Month-18%

Onconetix Financials at a Glance

Market Cap

$2.22M

Revenue (TTM)

$815.37K

Net Income (TTM)

$14.03M

EPS (TTM)

$-52.81

P/E Ratio

-0.01

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.62

Volume

147,639

Open

$0.48

Previous Close

$0.62

Daily Range

$0.45 - $0.62

52-Week Range

$0.44 - $14.86

ONCO News

No articles available.

ONCO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Onconetix

Industry

Biotechnology

Employees

8

CEO

Karina M. Fedasz, MBA, CPA

Headquarters

Cincinnati, OH 45202, US

ONCO Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

-8%

Net Income Margin

-17%

Return on Equity

-110%

Return on Capital

-40%

Return on Assets

-56%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

-2.92%

Stock Overview

Market Cap

$2.22M

Shares Outstanding

3.58M

Volume

147.64K

Short Interest

0.00%

Avg. Volume

327.98K

Financials (TTM)

Gross Profit

$632.91K

Operating Income

$6.34M

EBITDA

$6.33M

Operating Cash Flow

$9.68M

Capital Expenditure

$0.00

Free Cash Flow

$9.68M

Cash & ST Invst.

$5.22M

Total Debt

$48.77K

Onconetix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$303.60K

-57.4%

Gross Profit

$247.68K

-62.5%

Gross Margin

81.58%

N/A

Market Cap

$2.22M

N/A

Market Cap/Employee

$185.18K

N/A

Employees

12

N/A

Net Income

$5.67M

+119.3%

EBITDA

$1.28M

+95.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$5.17M

+158.8%

Accounts Receivable

$296.87K

+208.2%

Inventory

$149.96K

+134.0%

Long Term Debt

$24.36K

N/A

Short Term Debt

$24.41K

-99.7%

Return on Assets

-56.29%

N/A

Return on Invested Capital

-40.18%

N/A

Free Cash Flow

$3.09M

-235.4%

Operating Cash Flow

$3.09M

-236.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
REVBRevelation Biosciences, Inc.
$1.19-0.83%
INDPIndaptus Therapeutics, Inc.
$1.70-3.41%
AZTRAzitra, Inc.
$0.28+60.59%
PTIXProtagenic Therapeutics, Inc.
$0.66-5.04%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About ONCO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.